Raloxifene Hydrochloride Tablet, Coated
Product Images NDC 71209-082

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 71209-082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cont-label-60mg-100-tab.jpg (Cont Label 60mg 100 Tab)

These are Raloxifene Hydrochloride tablets in a package containing 100 tablets of 60mg each. The tablets should be stored at a temperature between 20-25°C (66710 77%) with the permission of usage between 16°10 30 (60°10 86F). The medication is sold in the USP Controlled Room Temperature and should be taken as prescribed in the package insert. To maintain the quality of the medication, it should be kept in airtight containers with closures that resist children. The package includes a Medication Guide which should be given to each patient by the pharmacist. These tablets were manufactured by Cadila Pharmaceuticals Ltd. from Gujarat, India.*

FDA Label Image

Cont Label 60mg 1000 Tab

This is a medication label for Raloxifene Hydrochloride Tablets, USP produced by Cadila Pharmaceuticals. Each film-coated tablet contains 60 mg of raloxifene hydrochloride. It should be stored at a temperature between 20-25°C with a permissible excursion between 15-30°C. The usual adult dosage should be referred to the package insert for prescribing information. The medication should be kept out of reach of children and cannot be used if the inner seal is broken or missing. It comes in a child-resistant container, and the pharmacist should dispense the accompanying medication guide to each patient. Mig. Lic. No. G/1500.*

FDA Label Image

Cont-label-60mg-2000-tab.jpg (Cont Label 60mg 2000 Tab)

This is a description of a medication called Raloxifene Hydrochloride, which comes in tablet form. It should be stored at a temperature between 20° to 25°C and kept in a tight container with a child-resistant closure. The usual adult dosage is available in the package insert for prescribing information. It is manufactured by Cadila Pharmaceuticals Ltd. in India. The scan has some errors and typos, but the text is mostly readable.*

FDA Label Image

Cont-label-60mg-30-tab.jpg (Cont Label 60mg 30 Tab)

FDA Label Image

Raloxifene-spl-figure-1 (Raloxifene Spl Figure 1)

Total hip mean percentage change from baseline data for placebo and Raloxifene Hydrochloride subjects after 24 months from studies NA and EUS, and for all placebo, Raloxifene Hydrochloride, and CE subjects after 24 months from study INT (for hysterectomized women). The text also mentions Ruletene Hydeochoride and S Biptene Hysrochorive, but it is not clear what they refer to.*

FDA Label Image

Raloxifene-spl-strc.jpg (Raloxifene Spl Strc)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.